contraindications for glp-1 agonists include Receptor the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes GLP-1RA Essentials in Gastroenterology: Side

Can biomarkers predict which patients will experience significant shedding before it occurs

Strength training plays a particularly powerful role

I dont want to dive too deep on these pathways but regardless these provide further anti-inflammatory benefits along with basically telling your cells to get rid of your garbage, so it doesnt cause problems

Are you seeing clinicians think in terms of responder profiles yet, or is it still mostly peak-efficacy framing

Here to teach us once more is Carley Moses, who I really REALLY hope you remember from her previous posts on chronic care management and adult vaccinations

The GIP component is hypothesized to provide an additional mechanism to buffer against the hyperglycemic effects of glucagon [940], thus permitting triple agonists of higher potency at the glucagon receptor that in theory could drive more body weight loss